Baker Biotech Capital (GP), LLC Insider Trading $IBPI Ardea Biosciences, Inc./DE
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in Ardea Biosciences, Inc./DE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,646,964 shares
Latest Transaction: Dec 19 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in Ardea Biosciences, Inc./DE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 11.14 | 46,195 | 514,612 | 46,195 | |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.14 | 184,780 | 2,058,449 | 1,646,964 | 1.5 M to 1.6 M (+12.64 %) |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 11.14 | 46,195 | 514,612 | 46,195 | |
| Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.14 | 184,780 | 2,058,449 | 1,646,964 | 1.5 M to 1.6 M (+12.64 %) |
| May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | C | 0.00 | 56 | 0 | 0 | |
| May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | C | 0.00 | 294,624 | 0 | 1,462,184 | 1.2 M to 1.5 M (+25.23 %) |
| Apr 21 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.28 | 11,044 | 146,664 | 1,167,560 | 1.2 M to 1.2 M (+0.95 %) |
| Apr 08 2008 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.28 | 76,141 | 1,011,152 | 1,156,516 | 1.1 M to 1.2 M (+7.05 %) |
| Dec 21 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.25 | 298,040 | 3,949,030 | 1,078,767 | 780.7 K to 1.1 M (+38.17 %) |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | X | 1.03 | 147,313 | 152,174 | 0 | |
| Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | X | 1.03 | 147,313 | 152,174 | 777,506 | 630.2 K to 777.5 K (+23.38 %) |
| Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 12,701 | 76,206 | 625,292 | 612.6 K to 625.3 K (+2.07 %) |
| Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.98 | 4,242 | 25,386 | 612,591 | 608.3 K to 612.6 K (+0.70 %) |
| Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 5.28 | 20,347 | 107,365 | 608,349 | 588 K to 608.3 K (+3.46 %) |
| Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 4.83 | 6,351 | 30,675 | 588,002 | 581.7 K to 588 K (+1.09 %) |
| Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 4.77 | 8,917 | 42,522 | 581,651 | 572.7 K to 581.7 K (+1.56 %) |
| Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 4.00 | 29,722 | 118,888 | 572,734 | 543 K to 572.7 K (+5.47 %) |
| Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 3.85 | 55,378 | 213,266 | 543,012 | 487.6 K to 543 K (+11.36 %) |
Page: 1